Friday, September 12, 2025
HomeIndustriesHealthcare

Healthcare

Largest Study to Date Demonstrates Most Blood Cancer Patients Benefit From a Third Primary Dose of mRNA COVID-19 Vaccine

While one in four blood cancer patients do not produce detectable antibodies after their first two doses of the COVID-19 vaccine, 43% of them...

FDA Approves Optilume Urethral Drug Coated Balloon, a breakthrough treatment for urethral strictures

Urotronic, Inc., a Minnesota based medical device company, announced that the U.S. Food and Drug Administration (FDA) has approved the Optilume Urethral Drug Coated...

Medo AI and Medical Imaging Consultants announce partnership to simplify diagnostic ultrasound imaging.

Medo, a technology startup and world leader in using artificial intelligence (AI) to drastically simplify ultrasound in healthcare, and Medical Imaging Consultants (MIC), Western...

Brii Bio Announces Amubarvimab/Romlusevimab Combination Retains Neutralizing Activity Against Omicron SARS-CoV-2 Variant

Brii Biosciences Limited , a multi-national company developing innovative therapies for diseases with significant unmet medical needs and large public health burdens, announced new...

PharmaMar and Jazz Pharmaceuticals Announce Initiation of Confirmatory Phase 3 Clinical Trial of Zepzelca® (lurbinectedin) for the Treatment of Patients with Relapsed Small Cell...

PharmaMar and partner Jazz Pharmaceuticals plc announced the initiation of a confirmatory Phase 3 clinical trial, LAGOON, evaluating Zepzelca® (lurbinectedin) for the treatment of...
0FansLike
0FollowersFollow
spot_img

Hot Topics